Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNPH1 | O43598 | 11/20 | 0.77 |
| ▸ | P2RY1 | P47900 | 4/20 | 0.77 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.77 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.77 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.77 |
| ▸ | SRC | P12931 | 2/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.77 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.77 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.77 |
| ▸ | LDHA | P00338 | 1/20 | 0.77 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.77 |
| ▸ | FBP1 | P09467 | 1/20 | 0.77 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.77 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.77 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.77 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.77 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.77 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.77 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.77 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30586256 | 1.00 | DNPH1 (0.77) | DNPH1P2RY1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL29973883 | 1.00 | DNPH1 (0.77) | DNPH1P2RY1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL888031 | 1.00 | DNPH1 (0.77) | DNPH1P2RY1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL19255 | 0.99 | DNPH1 (0.79) | DNPH1P2RY1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL16141757 | 0.99 | DNPH1 (0.79) | DNPH1P2RY1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL25168081 | 0.99 | DNPH1 (0.79) | DNPH1P2RY1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL11645423 | 0.99 | DNPH1 (0.79) | DNPH1P2RY1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL24145247 | 0.99 | DNPH1 (0.79) | DNPH1P2RY1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL161318 | 0.99 | DNPH1 (0.79) | DNPH1P2RY1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL29358651 | 0.99 | DNPH1 (0.79) | DNPH1P2RY1TAS1R3TAS1R1P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119867322-A | Formula powder for phenylketonuria patients and preparation method thereof | 君乐宝乳业集团股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119817824-A | Formula powder for maple diabetes patients and preparation method thereof | 君乐宝乳业集团股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119547901-A | Rice balanced nutrition strengthening additive for improving rice quality of aged rice and preparation method thereof | 吕钟舟 | 2025-03-04 | — | — | CN | claimed |
| CN-119423167-A | Critical nutrition golden ratio synergistic milk powder and aseptic proportioning equipment thereof | 圣元营养食品有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118947827-A | Bullfrog crowding stress resistant feed additive, preparation method and feed preparation device | 展翔饲料集团有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118216575-A | Infant milk powder with high whey protein content and preparation method thereof | 圣元营养食品有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118215670-A | Method for producing mixed crystal of disodium 5 '-guanylate and disodium 5' -inosinate | 味之素株式会社 | 2024-06-18 | — | — | CN | claimed |
| CN-115530314-B | Application of disodium 5 '-inosinate and disodium 5' -guanylate as acrolein inhibitor | 南京师范大学 | 2024-04-19 | — | — | CN | claimed |
| CN-115227706-B | Application of nucleotide 5' -monophosphate composition in preparation of fat-reducing and weight-losing functional foods and medicines | 陈玉松 | 2023-12-29 | — | — | CN | claimed |
| CN-114190543-B | Lactose-free formula food for infants with low osmotic pressure and special medical application | 青岛圣桐营养食品有限公司 | 2023-05-26 | — | — | CN | claimed |
| CN-111436597-B | Lipotide and its production process | 山东若尧特医食品有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-115530314-A | Application of disodium 5 '-inosinate and disodium 5' -guanylate as acrolein inhibitor | 南京师范大学 | 2022-12-30 | — | — | CN | claimed |
| CN-114176219-B | Hypoallergenic milk protein partial hydrolysis formula food and preparation method thereof | 青岛圣桐营养食品有限公司 | 2022-10-04 | — | — | CN | claimed |
| CN-113519805-B | Nucleotide probiotic pickled vegetables capable of regulating intestinal flora and preparation method of nucleotide probiotic pickled vegetables | 陈玉松 | 2022-03-25 | — | — | CN | claimed |
| US-12350377-B2 | Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives | SHIONOGI & CO., LTD. (JP) | 2025-07-08 | — | — | US | disclosed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119902505-A | Intelligent production control method and device for amino acid formula powder | 山东美吉客生物科技有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-113519805-B | Nucleotide probiotic pickled vegetables capable of regulating intestinal flora and preparation method of nucleotide probiotic pickled vegetables | 陈玉松 | 2022-03-25 | — | — | CN | disclosed |
| CN-114209042-A | Hollow dietary salt and application thereof | 上海来伊份股份有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-111748592-B | Preparation method of high-purity flavor nucleotide disodium | 通辽梅花生物科技有限公司 | 2022-03-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12350377-B2 | Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives | F7, TTN, CYP3A7 | DNPH1 2176/4885P2RY1 4026/4885TAS1R3 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.